Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

822.51 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Mar 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
1 Growth Stock With Major Catalysts on the Way to Buy and Hold
Via The Motley Fool
Is Hims & Hers Stock Too Cheap to Pass Up?
This high-growth stock may be cheaper than you think. 
Via The Motley Fool
Benzinga Bulls And Bears: Chevron, Microsoft, Nike — And Tariffs Have Automotive Sector Reeling
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories. 
Via Benzinga
Microsoft Co-Founder Bill Gates Praises China As A Pioneer In Solar, Batteries, And AI: Warns Tensions Are Stifling Global Innovation
Bill Gates criticized escalating U.S.-China tensions for hindering global access to critical green technologies, praising China as a global leader in solar, batteries, and AI while warning that... 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Eli Lilly Stock Up 1% After Key Signal, Despite S&P 500's ~2% Drop
Eli Lilly shares demonstrated a power inflow at $821.70, after which LLY rose up to 1%, while S&P 500 dropped nearly 2% today. 
Via Benzinga
Topics Stocks
Exposures US Equities
European Drug Regulator Gives Thumbs Down To Eli Lilly's Alzheimer's Drug, Analyst Says It Is Incremental Win For Biogen
Eli Lilly's donanemab faces a setback as EMA's CHMP issues a negative opinion. Analysts expect Lilly to appeal, citing past reversals in similar cases. 
Via Benzinga
Novo Nordisk Inks Its Second Big Obesity Deal In A Week — And It's Not For A GLP-1
The company is looking for drugs it can add to Wegovy to improve the amount of weight lost. 
Via Investor's Business Daily
Investors Are Flocking to These 3 Vanguard Sector ETFs. Should You Buy Them Too?
Via The Motley Fool
Topics ETFs Economy Government
Exposures Economy Political Tariff
Billionaires Stanley Druckenmiller, Chase Coleman, and Stephen Mandel Jr. Are Piling Into This Growth Stock That's Beating the S&P 500
Via The Motley Fool
Topics Stocks
Exposures US Equities
Here's How Much $1000 Invested In Eli Lilly 20 Years Ago Would Be Worth Today
Via Benzinga
Why Novo Nordisk Stock Dipped on Thursday
Via The Motley Fool
How Tariffs Are Rocking The 'Bubblegum And Shoestring' Medical Supply Chain
Uncertainty has cast a pall over medical stocks, which are taking a "wait-and-see" approach to Trump's tariffs. 
Via Investor's Business Daily
Topics Government
Exposures Political
1 Growth Stock Down 40% to Buy and Hold Forever
Via The Motley Fool
Beyond GLP-1 Drugs: This Opportunity at Eli Lilly Could Surprise Everyone in 2025
Mounjaro and Zepbound are Eli Lilly's largest sources of growth, but there is much more to the company. 
Via The Motley Fool
Price Targets Show These 3 Stocks Near the $1 Trillion Mark
See what analysts' price targets say about the prospects of these three stocks flirting with the $1 trillion valuation mark. 
Via MarketBeat
Novo Nordisk Stock Sinks To 52-Week Lows: Weight Loss Boom Losing Steam?
Novo Nordisk is betting on the future with a $2-billion deal to buy rights to a Chinese obesity drug. But investors remain unimpressed. 
Via Benzinga
Viking Therapeutics Skids Despite 'Rapid' Enrollment In Obesity Pill Study
The "rapid" enrollment suggests there's still huge interest in the company's approach to obesity treatment. 
Via Investor's Business Daily
Eli Lilly, Palo Alto Networks Traders Take Note: Direxion's New Leveraged ETFs Are Here
According to Direxion CEO Douglas Yones, Eli Lilly and Palo Alto Networks are prime candidates for leveraged trading. 
Via Benzinga
Topics ETFs
Direxion Expands Single Stock Leveraged & Inverse ETF Lineup for Exposure to Eli Lilly & Palo Alto Networks
Extends Leadership Role with First-Ever Palo Alto Networks Trading Pair, Alongside New Pharma Trades 
Via News Direct
Topics ETFs
2 No-Brainer Growth Stocks to Buy and Hold Forever
Via The Motley Fool
Eli Lilly Shares Rise Over 2% After Key Signal
A significant trading signal occurred for Eli Lilly stock, as it demonstrated a Power Inflow at $849.02, after which LLY rose up to 2.1% 
Via Benzinga
5 Stocks That Could Be The Next Nvidia
Via Benzinga
Why Novo Nordisk Stock Dropped on Monday, but Eli Lilly and Him & Hers Health Popped
There's a price war brewing in GLP-1 weight loss drugs, and now it's going global. 
Via The Motley Fool
Eli Lilly Unusual Options Activity
Via Benzinga
Novo Nordisk Finds A New Way To Rival Eli Lilly. But Shares Tumble.
Novo Nordisk is now planning to take on Eli Lilly's experimental retatrutide, a triple agonist for weight loss and diabetes. 
Via Investor's Business Daily
Market Sell-Off: Can Buying These 3 "Safe" Stocks Today Set You Up for Life?
These fundamentally strong stocks remain safer picks, despite the heightened market volatility. 
Via The Motley Fool
China Courts Apple, Pfizer, Eli Lilly Amid US Pressure, Vice Premier Says Beijing 'Will Continue To Improve The Business Environment'
China is stepping up efforts to reassure U.S. corporate giants like Apple, Pfizer, and Mastercard of its economic potential, with Vice Premier He Lifeng promising a better business environment amid... 
Via Benzinga
Topics World Trade
Exposures Tariff
Stop Chasing Returns And Start Getting Rising Dividends With These 10 Blue Chip Stocks
Instead of chasing returns, investors can start building long-term passive income through dividend growth stocks. 
Via Talk Markets
Topics Stocks / Equities
AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
Abbvie made an all-time high after announcing an agreement that puts it in the weight loss market; but that just continues a general uptrend in ABBV stock 
Via MarketBeat
Better Stock to Buy Right Now: Viking Therapeutics vs. Eli Lilly
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.